Cited by

• Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

  Briasoulis E, Aravantinos G, Kouvatseas G, Pappas P, Biziota E, Sainis I, Makatsoris T, Varthalitis I, Xanthakis I, Vassias A, Klouvas G, Boukovinas I, Fountzilas G, Syrigos KN, Kalofonos H, Samantas E. Briasoulis E, et al. BMC Cancer. 2013 May 29;13:263. doi: 10.1186/1471-2407-13-263. BMC Cancer. 2013. PMID: 23718900 Free PMC article. Clinical Trial.
• Alkylating agent resistance: in vitro studies with human cell lines.

  Frei E 3rd, Cucchi CA, Rosowsky A, Tantravahi R, Bernal S, Ervin TJ, Ruprecht RM, Haseltine WA. Frei E 3rd, et al. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2158-62. doi: 10.1073/pnas.82.7.2158. Proc Natl Acad Sci U S A. 1985. PMID: 3856890 Free PMC article.
• Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.

  Aamdal S, Fodstad O, Pihl A. Aamdal S, et al. Cancer Chemother Pharmacol. 1988;21(2):129-33. doi: 10.1007/BF00257358. Cancer Chemother Pharmacol. 1988. PMID: 3349560
• Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.

  Graham RA, Siddik ZH, Hohn DC. Graham RA, et al. Cancer Chemother Pharmacol. 1990;26(3):210-4. doi: 10.1007/BF02897201. Cancer Chemother Pharmacol. 1990. PMID: 2357769
• High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.

  Gomm SA, Thatcher N, Cuthbert A, Chang J, Burmester H, Hall P, Carroll KB. Gomm SA, et al. Br J Cancer. 1991 Feb;63(2):293-7. doi: 10.1038/bjc.1991.68. Br J Cancer. 1991. PMID: 1847648 Free PMC article. Clinical Trial.